Aurora Cannabis Inc. (TSX:ACB) and CanniMed Therapeutics Inc. (TSX:CMED) just announced that the two companies have entered a supportive agreement in which CanniMed’s board will support Aurora’s offer to acquire all of its issued and outstanding shares not already owned for a total consideration of approximately $1.1 billion.
The deal values CanniMed at approximately $43 per share, which represents a 181% premium over its closing price on November 14, 2017, the trading session prior to Aurora’s public disclosure that it would pursue a takeover of CanniMed. The deal also represents a 79% increase from its previous offer of $24 per share, which CanniMed strongly opposed, and a 14.6% premium to its closing price of $37.51 on Tuesday.
The deal comes less than a week after the two companies reached an agreement to discuss a possible transaction, which was extended twice in order to give the two management teams enough time to complete the deal it just announced.
As a part of this deal, CanniMed has entered a termination agreement with Newstrike Resources Ltd. (TSXV:HIP), which it was in the process of acquiring as a way to prevent the takeover by Aurora, and this termination will result in a $9.5 million breakup fee that will be paid to Newstrike.
I think this is a phenomenal deal for CanniMed’s shareholders, so I would most certainly vote in favour of it.
I also think this is a phenomenal deal for Aurora, because the combination of the two companies will create a powerhouse in the cannabis industry with the size and scale to compete with the other powerhouses, Canopy Growth Corp. and Aphria Inc.
With all of this being said, I think Foolish investors seeking exposure to the high-growth cannabis industry should strongly consider beginning to scale in to long-term positions in Aurora, Canopy, or Aphria over the next couple of weeks.
While conflict overseas is all media talking-heads seem to mention these days, the billionaire founder of Tesla is losing sleep over what he sees as a far bigger threat.
Elon Musk Warns: This has “vastly more risk than North Korea”
If you missed your opportunity to get in on Google, Microsoft, or Amazon in their early days, don't let it happen again. This emerging technology trend could offer a second chance for anyone who wishes they took part in these millionaire-maker stocks.
Fool contributor Joseph Solitro has no position in any stocks mentioned.